Literature DB >> 7942276

Human casein kinase II: structures, genes, expression and requirement in cell growth stimulation.

W Pyerin1.   

Abstract

Casein kinase II (CKII) is an ubiquitous Ser/Thr protein phosphotransferase in control of a variety of crucial cellular functions including metabolism, signal transduction, transcription, translation and replication. CKII levels are consistently higher in neoplastic tissues. The human CKII is composed of subunits alpha, alpha', and beta with molecular masses of 43, 38 and 28 kDa, respectively, that form heterotetrameric holoenzymes (alpha 2 beta 2; alpha alpha' beta 2, alpha'2 beta 2) showing autophosphorylation particularly at subunit beta and hence suspected to play a regulatory role. The amino acid sequences of subunits indicate high evolutionary conservation. Employing the complete set of tissue-derived (placenta) and recombinant (expressed in E. coli) subunits and CKII holoenzymes, the catalytic function of alpha and alpha' and the several-fold stimulation by beta is shown to occur comparably in tissue-derived and recombinant CKII and the autophosphorylation of beta is shown by site-directed mutagenesis to be not decisive for the tuning of CKII activity. The human genome contains two genes encoding CKII alpha. First, there is a processed (pseudo)gene which is 99% homologous to the CKII alpha cDNA and which possesses a promoter-like region adjacently upstream with TATA and CAAT boxes so that transcription cannot be excluded. Second, there is an active gene of which we have characterized so far a 18.9 kb long central fragment which contains 8 exons comprising bases 102-824 of the CKII alpha coding region. The gene fragment contains repetitive elements, most prominently 16 Alu repeats. The genome further contains one as yet uncharacterized CKII alpha' gene and one gene encoding CKII beta. The CKII beta gene has been characterized as a 4.2 kb spanning gene composed of seven exons which possesses three transcription start sites and the translation start site in the second exon. The first intron harbors an Alu repeat also. The promoter region of the CKII beta gene contains elements such as multiple GC boxes, a CpG island, and nonstandard-positioned CAAT boxes but lacks a TATA box thus characterizing the gene as a housekeeping gene. The CKII genes are not clustered at a certain chromosome but rather are distributed over the whole human genome. Using the genomic clones as the probes for in situ hybridization, the active CKII alpha gene was mapped to chromosome 20p13, the processed CKII alpha (pseudo)gene to chromosome 11p15, and the CKII beta gene to chromosome 6p21. (The CKII alpha' gene has been localized on chromosome 16 with a cDNA probe.).(ABSTRACT TRUNCATED AT 400 WORDS)

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7942276     DOI: 10.1016/0065-2571(94)90018-3

Source DB:  PubMed          Journal:  Adv Enzyme Regul        ISSN: 0065-2571


  9 in total

1.  Intermolecular contact sites in protein kinase CK2.

Authors:  A Krehan; W Pyerin
Journal:  Mol Cell Biochem       Date:  1999-01       Impact factor: 3.396

2.  Transcriptional coordination of the genes encoding catalytic (CK2alpha) and regulatory (CK2beta) subunits of human protein kinase CK2.

Authors:  W Pyerin; K Ackermann
Journal:  Mol Cell Biochem       Date:  2001-11       Impact factor: 3.396

3.  Genes targeted by protein kinase CK2: a genome-wide expression array analysis in yeast.

Authors:  K Ackermann; A Waxmann; C V Glover; W Pyerin
Journal:  Mol Cell Biochem       Date:  2001-11       Impact factor: 3.396

4.  Third colloquium on cellular signal transduction: cell-cycle signalling. German Cancer Research Centre Heidelberg, 14 January 1994.

Authors:  F Marks; D Werner
Journal:  J Cancer Res Clin Oncol       Date:  1994       Impact factor: 4.553

5.  cAMP has distinct acute and chronic effects on aquaporin-5 in lung epithelial cells.

Authors:  Venkataramana Sidhaye; Jason D Hoffert; Landon S King
Journal:  J Biol Chem       Date:  2004-11-09       Impact factor: 5.157

6.  Characterization, subcellular localization and nuclear targeting of casein kinase 2 from Zea mays.

Authors:  G Peracchia; A B Jensen; F A Culiáñez-Macià; J Grosset; A Goday; O G Issinger; M Pagès
Journal:  Plant Mol Biol       Date:  1999-05       Impact factor: 4.076

7.  Binding of FGF-1 variants to protein kinase CK2 correlates with mitogenicity.

Authors:  Camilla Skiple Skjerpen; Trine Nilsen; Jørgen Wesche; Sjur Olsnes
Journal:  EMBO J       Date:  2002-08-01       Impact factor: 11.598

Review 8.  The Hsp70/Hsp90 Chaperone Machinery in Neurodegenerative Diseases.

Authors:  Rachel E Lackie; Andrzej Maciejewski; Valeriy G Ostapchenko; Jose Marques-Lopes; Wing-Yiu Choy; Martin L Duennwald; Vania F Prado; Marco A M Prado
Journal:  Front Neurosci       Date:  2017-05-16       Impact factor: 4.677

Review 9.  The Role of Protein Kinase CK2 in Development and Disease Progression: A Critical Review.

Authors:  Daniel Halloran; Venu Pandit; Anja Nohe
Journal:  J Dev Biol       Date:  2022-07-27
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.